MedPath

Effect of non surgical periodontal therapy in treatment of diabetes

Not Applicable
Recruiting
Conditions
Condition 1: moderate chronic periodontitis. Condition 2: Type 2 diabetes mellitus.
Chronic periodontitis
Type 2 diabetes mellitus
K05.3
Registration Number
IRCT20190721044287N1
Lead Sponsor
Rasht University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
42
Inclusion Criteria

Patients with chronic periodontitis who have not received any periodontal treatment in the past 6 months
Periodontal patients who have not received any antimicrobial treatment in the past 3 months
Patients with at least 14 teeth in mouth and pocket depth = 5 mm in at least 4 areas and clinical attachment loss =3 mm in at least 4 areas
Diabetes diagnosed by a physician for about 6 months
Patients unchanged in their diabetic drug regimen for the past 3 months

Exclusion Criteria

Patients with advanced diabetic problems (macrovascular and microvascular)
Chronic pulmonary disease
Kidney and liver disease
Malignancies
Heart disease (coronary artery disease)
Transplanted patients
History of infection and trauma
Alcoholic and Smoker Patients
Pregnant people
Patients with severe periodontitis

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hb A1c. Timepoint: At baseline and 3 months later. Method of measurement: Sebia apparatus for measuring Hba1c using electrophoresis capillary kit.;C1 Reactive Protein. Timepoint: At baseline and 3 month later. Method of measurement: Hitachi912 apparatus for measuring c1 reactive protein using bionik kit.;Clinical attachment loss index. Timepoint: At baseline and 3 months later. Method of measurement: Using William's periodontal probe.;Gingival index. Timepoint: At baseline and 3 month later. Method of measurement: Using Leo & Sillness gingival inflammation index.;Pocket depth index. Timepoint: At baseline and 3 month later. Method of measurement: Using William's periodontal probe.;Gingival bleeding index. Timepoint: At baseline and 3 month later. Method of measurement: Using William's periodontal probe.;Plaque index. Timepoint: At baseline and 3 month later. Method of measurement: Using disclosing agent by O'leary Index method.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath